E-LIB Suche - Ergebnisse für: Fougeray, S.

1

Increased Body Mass Index After Kidney Transplantation in A..:

Fougeray, S. ; Loriot, M.-A. ; Nicaud, V....
Transplantation Proceedings. 43 (2011) 9 - p. 3418-3422 , 2011

Link: https://doi.org/10.1016/..

2

In-vivo effects of epidermal growth factor in high dilution:

Bastide, M. ; Pham Duc, T.L. ; Papconstantin, E.A....
British Homeopathic Journal. 84 (1995) 3 - p. 177-178 , 1995

Link: https://doi.org/10.1016/..

3

Effect of high dilutions of epidermal growth factor (EGF) o..:

Bastide, M. ; Vallot, N. ; Moubry, K..
British Homeopathic Journal. 82 (1993) 2 - p. 124-125 , 1993

Link: https://doi.org/10.1016/..

4

Neuroblastoma chemotherapy can be augmented by immunotarget..:

Faraj, S ; Bahri, M ; Fougeray, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739551/. , 2017

Link: http://www.ncbi.nlm.nih...

5

Metabolic stress promotes renal tubular inflammation by tri..:

Fougeray, S ; Bouvier, N ; Beaune, P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122058. , 2011

Link: http://www.ncbi.nlm.nih...

6

Neuroblastoma chemotherapy can be augmented by immunotarget..:

S. Faraj ; M. Bahri ; S. Fougeray...
http://dx.doi.org/10.1080/2162402X.2017.1373232. , 2018

Link: https://doi.org/10.1080/..

7

A UK cost–effectiveness analysis of trifluridine/tipiracil ..:

Hamerton, Leanne ; Gomes, Kelly ; Fougeray, Ronan...
Future Oncology. 19 (2023) 9 - p. 643-650 , 2023

Link: https://doi.org/10.2217/..

8

Zac1 and the Imprinted Gene Network program juvenile NAFLD ..:

Baptissart, Marine ; Bradish, Christine M. ; Jones, Brie S....
Hepatology. 76 (2022) 4 - p. 1090-1104 , 2022

Link: https://doi.org/10.1002/..

9

Trifluridine/tipiracil versus placebo for third or later li..:

Tabernero, J. ; Shitara, K. ; Zaanan, A....
ESMO Open. 6 (2021) 4 - p. 100200 , 2021

Link: https://doi.org/10.1016/..

10

Regulation of hepatokine gene expression in response to fas..:

Smati, S. ; Régnier, M. ; Fougeray, T....
Diabetes & Metabolism. 46 (2020) 2 - p. 129-136 , 2020

Link: https://doi.org/10.1016/..

11

Complete Response as an Intermediate End Point in Patients ..:

Sonpavde, Guru ; Pond, Gregory R. ; Rosenberg, Jonathan E....
Clinical Genitourinary Cancer. 13 (2015) 2 - p. 185-192 , 2015

Link: https://doi.org/10.1016/..

12

2640 Vinflunine maintenance treatment following first-line ..:

De Wit, M. ; De Geeter, P. ; Galli, L....
European Journal of Cancer. 51 (2015) - p. S527 , 2015

Link: https://doi.org/10.1016/..

13

Impact of the Number of Prior Lines of Therapy and Prior Pe..:

Pond, G.R. ; Bellmunt, J. ; Rosenberg, J.E....
Clinical Genitourinary Cancer. 13 (2015) 1 - p. 71-79 , 2015

Link: https://doi.org/10.1016/..

14

Patient Eligibility and Trial Design for the Salvage Therap..:

Sonpavde, Guru ; Bellmunt, Joaquim ; Rosenberg, Jonathon E....
Clinical Genitourinary Cancer. 12 (2014) 6 - p. 395-398 , 2014

Link: https://doi.org/10.1016/..

15

A nomogram including baseline prognostic factors to estimat..:

Pond, Gregory R. ; Agarwal, Neeraj ; Bellmunt, Joaquim...
BJU International. 113 (2014) 5b - p. , 2014

Link: https://doi.org/10.1111/..